Atlas Trials

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Practice

Clinical trial NCT06763146 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06763146
Sponsor
Bayer
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Start date
2025-09-22
Primary completion
2026-09-30
Enrollment
1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.